Oppenheimer Upgrades Agios Pharma On Expectations For First Drug Launch

By: via Benzinga
Oppenheimer has upgraded Agios Pharmaceuticals Inc (NASDAQ: AGIO) shares to Outperform from Perform on higher expectations for its first ...
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.